[en] Aside from limb tremor, bradykinesia, rigidity and gait disturbances, Parkinson's disease (PD) is also characterized by non-motor symptoms. A cognitive decline can occur early in the disease course and undoubtedly impact of the patient's quality of life. Dementia affects 80% of patients 20 years after disease onset but a small subgroup of patients remain free of dementia even after decades with PD. Risk factors and diagnosis of dementia can be easily assessed using bed-side clinical instruments. Advances in genetics and imagery will allow improving the diagnosis and therapeutic strategy dementia in Parkinson's disease.
Research Center/Unit :
GIGA CRC (Cyclotron Research Center) In vivo Imaging-Aging & Memory - ULiège
Disciplines :
Neurology Neurosciences & behavior
Author, co-author :
BAKAY, Sara ; Centre Hospitalier Universitaire de Liège - CHU > Psychiatrie et psychologie médicale
BECHET, Sophie ; Centre Hospitalier Universitaire de Liège - CHU > Neurochirurgie
Hely MA, Reid WG, Adena MA, et al. - The Sydney multicenter study of Parkinson's disease : the inevitability of dementia at 20 years. Mov Disord, 2008, 23, 837-844.
Emre M, Aarsland D, Brown R, et al. - Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord, 2007, 22, 1689-1707. (Pubitemid 47597592)
Halliday G, Hely M, Reid W, Morris J. - The progression of pathology in longitudinally followed patients with Parkinson's disease. Acta Neuropathol, 2008, 115, 409-415.
Aarsland D, Zaccai J, Brayne C. - A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord, 2005, 20, 1255-1263. (Pubitemid 41645899)
Aarsland D, Kurz MW. - The epidemiology of dementia associated with Parkinson disease. J Neurol Sci, 2010, 289, 18-22.
Williams-Gray C H, Evans JR, Goris A, et al. - The distinct cognitive syndromes of Parkinson's disease : 5 year follow-up of the CamPaIGN cohort. Brain, 2009, 132, 2958-2969.
Aarsland D, Kvaloy JT, Andersen K, et al. - The effect of age of onset of PD on risk of dementia. J Neurol, 2007, 254, 38-45. (Pubitemid 46295066)
Alves G, Larsen JP, Emre M, et al. - Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord, 2006, 21, 1123-1130. (Pubitemid 44336596)
Williams-Gray CH, Foltynie T, Brayne CE, et al. - Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain, 2007, 130, 1787-1798. (Pubitemid 47343805)
Dubois B, Burn D, Goetz C, et al. - Diagnostic procedures for Parkinson's disease dementia : recommendations from the movement disorder society task force. Mov Disord, 2007, 22, 2314-2324. (Pubitemid 351155975)
Santangelo G, Trojano L, Vitale C, et al. - A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. Mov Disord, 2007, 22, 2418-2425. (Pubitemid 351155990)
Scott WK, Nance MA, Watts RL, et al. - Complete genomic screen in Parkinson disease : evidence for multiple genes. JAMA, 2001, 286, 2239-2244. (Pubitemid 33063145)
Healy DG, Abou-Sleiman PM, Lees AJ, et al. - Tau gene and Parkinson's disease : a case-control study and meta-analysis. J Neurol Neurosurg Psychiatry, 2004, 75, 962-965. (Pubitemid 38869606)
Goris A, Williams-Gray CH, Clark GR, et al. - Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease. Ann Neurol, 2007, 62, 145-153. (Pubitemid 47546500)
Hosokai Y, Nishio Y, Hirayama K, et al. - Distinct patterns of regional cerebral glucose metabolism in Parkinson's disease with and without mild cognitive impairment. Mov Disord, 2009, 24, 854-862.
Garraux G, Salmon E, Franck G. - Parietal hypometabolism in Parkinson's disease without dementia. Abstract. Park Dis Rel Dis, 1999, 5 (suppl 2), 38.
Hu MTM, Taylor-Robinson SD, Chaudhuri KR, et al. - Cortical dysfunction in non-demented Parkinson's disease patients : a combined (31)P-MRS and (18)FDG-PET study. Brain, 2000, 123, 340-352.
Hughes AJ, Daniel SE, Kilford L, Lees AJ. - Accuracy of clinical diagnosis of idiopathic Parkinson's disease : a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry, 1992, 55, 181-184.
Llebaria G, Pagonabarraga J, Kulisevsky J, et al. - Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease. Mov Disord, 2008, 23, 1546-1550.
Folstein MF, Folstein SE, MsHugh PR. - «Mini-Mental State» : a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 1975, 12, 189-198.
Emre M, Aarsland D, Albanese A, et al. - Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med, 2004, 351, 2509-2518. (Pubitemid 39603164)
Frieling H, Hillemacher T, Ziegenbein M, et al. - Treating dopamimetic psychosis in Parkinson's disease: structured review and meta-analysis. Eur Neuropsychopharmacol, 2007, 17, 165-171. (Pubitemid 44779199)
Rabey JM, Prokhorov T, Miniovitz A, et al. - Effect of quetiapine in psychotic Parkinson's disease patients : a double-blind labeled study of 3 months' duration. Mov Disord, 2007, 22, 313-318. (Pubitemid 46569682)
Salmon E. - Les Cahiers du troisième âge. Principes d'adaptation cognitive dans les démences. 2006, Wolters Kluwer Belgium SA, Waterloo.
Testad I, Ballard C, Bronnick K, Aarsland D. - The effect of staff training on agitation and use of restraint in nursing home residents with dementia : a single-blind, randomized controlled trial. J Clin Psychiatry, 2010, 71, 80-86.
Cruise KE, Bucks RS, Loftus AM, et al. - Exercise and Parkinson's : benefits for cognition and quality of life. Acta Neurol Scand, 2010, Epub ahead of print.
Cifu DX, Carne W, Brown R, et al. - Caregiver distress in parkinsonism. J Rehabil Res Dev, 2006, 43, 499-508.
